Casein kinase-1?1 and 3 stimulate tumor necrosis factor-induced necroptosis through RIPK3.
Ontology highlight
ABSTRACT: Upon necroptosis activation, receptor interacting serine/threonine kinase (RIPK)1 and RIPK3 form a necrosome complex with pseudokinase mixed lineage kinase-like (MLKL). Although protein phosphorylation is a key event for RIPK1 and RIPK3 activation in response to a necroptosis signal, relatively little is known about other factors that might regulate the activity of these kinases or necrosome formation. Through a gain-of-function screen with 546 kinases and 127 phosphatases, we identified casein kinase 1 gamma (CK1?) as a candidate necroptosis-promoting factor. Here, we show that the decreased activity or amounts of CK1?1 and CK1?3, either by treatment with a chemical inhibitor or knockdown in cells, reduced TNF?-induced necroptosis. Conversely, ectopic expression of CK1?1 or CK1?3 exacerbated necroptosis, but not apoptosis. Similar to RIPK1 and RIPK3, CK1?1 was also cleaved at Asp343 by caspase-8 during apoptosis. CK1?1 and CK1?3 formed a protein complex and were recruited to the necrosome harboring RIPK1, RIPK3 and MLKL. In particular, an autophosphorylated form of CK1?3 at Ser344/345 was detected in the necrosome and was required to mediate the necroptosis. In addition, in vitro assays with purified proteins showed that CK1? phosphorylated RIPK3, affecting its activity, and in vivo assays showed that the CK1?-specific inhibitor Gi prevented abrupt death in mice with hypothermia in a model of TNF?-induced systemic inflammatory response syndrome. Collectively, these data suggest that CK1?1 and CK1?3 are required for TNF?-induced necroptosis likely by regulating RIPK3.
SUBMITTER: Lee SY
PROVIDER: S-EPMC6892881 | biostudies-literature | 2019 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA